Endothelium-Derived Hyperpolarizing Factors and Vascular Cytochrome P450 Metabolites of Arachidonic Acid in the Regulation of Tone
- 5 March 1999
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 84 (4), 484-488
- https://doi.org/10.1161/01.res.84.4.484
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Endothelium-Derived Hyperpolarizing Factor Activates Ca2+-Activated K+ Channels in Porcine Coronary Artery Smooth Muscle CellsJournal of Cardiovascular Pharmacology, 1998
- Bioassay of an Endothelium-Derived Hyperpolarizing Factor from Bovine Coronary Arteries: Role of a Cytochrome P450 MetaboliteJournal of Vascular Research, 1998
- A transferable, beta-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells.The Journal of Physiology, 1996
- Acetylcholine releases endothelium‐derived hyperpolarizing factor and EDRF from rat blood vesselsBritish Journal of Pharmacology, 1988
- Endothelium-dependent hyperpolarization of smooth muscle cells in rabbit femoral arteries is not mediated by EDRF (nitric oxide)Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- Endothelium‐dependent hyperpolarization of canine coronary smooth muscleBritish Journal of Pharmacology, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Endothelial‐dependent relaxant actions of carbachol and substance P in arterial smooth muscleBritish Journal of Pharmacology, 1986
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976